Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $35.5300 (-3.76%) ($35.2000 - $36.8300) on Wed. Oct. 10, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.04% (three month average) | RSI | 39 | Latest Price | $35.5300(-3.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -3.4% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.52% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-12%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.52% (StdDev 3.04%) | Hourly BBV | 0 () | Intraday Trend | -3.5% | | | |
|
1 - 5 Day Possible Target | $30.32(-14.66%) | Resistance Level | $40.1 | 5 Day Moving Average | $38.13(-6.82%) | 10 Day Moving Average | $39.44(-9.91%) | 20 Day Moving Average | $40.1(-11.4%) | To recent high | -18.3% | To recent low | 1.4% | Market Cap | $2.64b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |